Ellen Lubman - Jan 2, 2024 Form 4 Insider Report for Werewolf Therapeutics, Inc. (HOWL)

Role
Chief Business Officer
Signature
/s/ Jonathan Owen, Attorney-in-fact
Stock symbol
HOWL
Transactions as of
Jan 2, 2024
Transactions value $
$0
Form type
4
Date filed
1/4/2024, 04:37 PM
Previous filing
Jan 9, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HOWL Stock Option (right to buy) Award $0 +132K $0.00 132K Jan 2, 2024 Common Stock 132K $4.64 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 2, 2024 with a Vesting Commencement Date of January 1, 2024. The shares underlying the option vest in equal monthly installments over four years, commencing on the date that is one month following the Vesting Commencement Date and vesting monthly thereafter through January 1, 2028.